{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:50:47Z","timestamp":1782384647170,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dmd.2026.100311","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:27:08Z","timestamp":1777480028000},"page":"100311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population pharmacokinetic analysis of onradivir to support dosing recommendations in elderly adults with influenza"],"prefix":"10.1016","volume":"54","author":[{"given":"Xiao-Jie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Xian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Heng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9186","key":"10.1016\/j.dmd.2026.100311_bib1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(99)01241-6","article-title":"Influenza","volume":"354","author":"Cox","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dmd.2026.100311_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.dmd.2026.100311_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100171","article-title":"Pharmacokinetic insights of onradivir in influenza treatment to inform pediatric dosing selection in clinical trial","volume":"53","author":"Li","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2026.100311_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S2213-2600(25)00128-6","article-title":"Onradivir: a novel influenza polymerase inhibitor","volume":"13","author":"Li","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.dmd.2026.100311_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(23)00743-0","article-title":"Onradivir Trial Recruitment and Medical Monitoring Group. Safety and efficacy of onradivir in adults with acute uncomplicated influenza A infection: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.dmd.2026.100311_bib6","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40265-025-02242-5","article-title":"Onradivir: first approval","volume":"85","author":"Lee","year":"2025","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.dmd.2026.100311_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.dmd.2026.100311_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","article-title":"Respiratory syncytial virus infection in elderly adults","volume":"22","author":"Falsey","year":"2005","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.dmd.2026.100311_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1472-8206.2007.00473.x","article-title":"Clinical pharmacology in the geriatric patient","volume":"21","author":"Hilmer","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100311_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp Gerontol"},{"issue":"11","key":"10.1016\/j.dmd.2026.100311_bib12","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1345\/aph.1E259","article-title":"Population pharmacokinetics II: estimation methods","volume":"38","author":"Ette","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.dmd.2026.100311_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcph.6134","article-title":"Single-dose tolerability and pharmacokinetics of onradivir in chinese patients with hepatic impairment and healthy matched controls","volume":"65","author":"Li","year":"2025","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2026.100311_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106452","article-title":"The impact of advanced age on gastrointestinal characteristics that are relevant to oral drug absorption: an AGePOP review","volume":"187","author":"Stillhart","year":"2023","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.dmd.2026.100311_bib16","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1345\/aph.1H174","article-title":"Pharmacokinetics of oseltamivir in young and very elderly subjects","volume":"40","author":"Abe","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.dmd.2026.100311_bib17","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/AAC.02438-12","article-title":"Population pharmacokinetics of oseltamivir: pediatrics through geriatrics","volume":"57","author":"Kamal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.dmd.2026.100311_bib18","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.xphs.2018.12.005","article-title":"Population pharmacokinetic and exposure-response analyses of baloxavir marboxil in adults and adolescents including patients with influenza","volume":"108","author":"Koshimichi","year":"2019","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.dmd.2026.100311_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00462-25","article-title":"Pharmacokinetics, safety, and tolerability of onradivir in participants with severe renal impairment and matched healthy control participants","volume":"69","author":"Li","year":"2025","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:24:27Z","timestamp":1782383067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0090955626000802"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100311","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic analysis of onradivir to support dosing recommendations in elderly adults with influenza","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100311"}}